ARCHIVES

Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.”

This article is from The Cancer Letter archive.

Vol. 31 No. 46 | December 16, 2005

Download PDF Visit The Full Archive

Related Articles

Increase Cancer Center Grants More Than R01s, SPOREs, Report Tells NCI

February 28, 2003

In Brief: Steve Carter Accepts Job With Bristol, Phillips Elected NCG Chairman; Murray Copeland Dies

April 9, 1982

Survivorship Studies Unfocused As Total Research Increases

November 25, 2011

In Brief: Upton Okays Laetrile Clinical Trials, To Seek Protocols From Clinicians For IND Request

October 6, 1978

Senate approves $1 billion increase for NIH; 3.7% raise is smallest since 1995.

September 19, 2003

Senate Votes Down Attempt to Cut NCI Funds $100 Million

October 3, 1975